Learn More
Invitrogen™ VSIG4 Monoclonal Antibody (JAV4), Super Bright™ 436, eBioscience™, Invitrogen™

Mouse Monoclonal Antibody
163.00 € - 393.00 €
Specifications
| Antigen | VSIG4 |
|---|---|
| Clone | JAV4 |
| Concentration | 5 μL/Test |
| Applications | Flow Cytometry |
| Classification | Monoclonal |
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
|---|---|---|---|---|---|---|---|---|---|
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
|
16361274
|
Invitrogen™
62-5757-41 |
25 Tests |
163.00 €
Pack of 25 |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
16371274
![]() |
Invitrogen™
62-5757-42 |
100 Tests |
393.00 €
Pack of 100 |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
Description
This JAV4 monoclonal antibody recognizes human V-Set and Immunoglobulin domain containing 4 (VSIG4), also known as Complement Receptor of the Immunoglobulin superfamily (CRIg) or Z39Ig. There are two variants of human VSIG4 that result from alternative sp
T cell activation by APCs is positively and negatively regulated by members of the B7 family. VSIG4 is a strong negative regulator of murine and human T cell proliferation and IL-2 production.Specifications
| VSIG4 | |
| 5 μL/Test | |
| Monoclonal | |
| Liquid | |
| RUO | |
| PBS with BSA and 0.09% sodium azide; pH 7.2 | |
| A530061A11; BC025105; complement receptor of the immunoglobulin superfamily; CRIg; Ig superfamily protein; MGC137243 protein; protein Z39Ig; UNQ317/PRO362; V-set and immunoglobulin domain containing 4; V-set and immunoglobulin domain-containing protein 4; VSIG4; Z39IG | |
| VSIG4 | |
| Primary | |
| 4°C, store in dark, DO NOT FREEZE! | |
| VSIG4 |
| JAV4 | |
| Flow Cytometry | |
| Super Bright 436 | |
| Mouse | |
| Human | |
| Q9Y279 | |
| 11326 | |
| IgG2a κ | |
| Affinity chromatography | |
| Antibody |
Your input is important to us. Please complete this form to provide feedback related to the content on this product.